Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?

Respirology

Volumn 20, Issue 5, 2015, Pages 722-729

  Gao, Wei ^a   Li, Lingling ^a   Wang, Yujie ^a   Zhang, Sini ^a   Adcock, Ian M ^b   Barnes, Peter J ^b   Huang, Mao ^a   Yao, Xin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

chronic obstructive pulmonary disease; epithelial cell; immunity; inflammation; oxidative stress

Indexed keywords

CHEMOKINE; CYTOKINE; REACTIVE OXYGEN METABOLITE;

AIRWAY REMODELING; BIOACCUMULATION; BRONCHIAL EPITHELIAL CELL; BRONCHUS MUCOSA; CELL ACTIVATION; CELL HYPERPLASIA; CELL MIGRATION; CELL REGENERATION; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; DISEASE COURSE; EFFECTOR CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GOBLET CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG INJURY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SQUAMOUS CELL METAPLASIA; TISSUE REGENERATION; AIRWAY OBSTRUCTION; DRUG EFFECTS; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA;

AIRWAY OBSTRUCTION; CHEMOKINES; EPITHELIAL CELLS; HUMANS; INFLAMMATION; LUNG; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA;

EID: 84931567493     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12542     Document Type: Review

References (69)

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et-al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347-365.
2. Hogg JC, Timens W,. The pathology of chronic obstructive pulmonary disease. Annu. Rev. Pathol. 2009; 4: 435-459.
3. Boers JE, Ambergen AW, Thunnissen FB,. Number and proliferation of basal and parabasal cells in normal human airway epithelium. Am. J. Respir. Crit. Care Med. 1998; 157 (6 Pt 1): 2000-2006.
4. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR,. In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 286: L643-649.
5. Knight DA, Holgate ST,. The airway epithelium: structural and functional properties in health and disease. Respirology 2003; 8: 432-446.
6. Evans CM, Koo JS,. Airway mucus: the good, the bad, the sticky. Pharmacol. Ther. 2009; 121: 332-348.
7. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL,. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 2008; 8: 142-152.
8. Vareille M, Kieninger E, Edwards MR, Regamey N,. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 2011; 24: 210-229.
9. Voynow JA, Rubin BK,. Mucins, mucus, and sputum. Chest 2009; 135: 505-512.
10. Müller L, Jaspers I,. Epithelial cells, the 'switchboard' of respiratory immune defense responses: effects of air pollutants. Swiss Med. Wkly 2012; 142: w13653.
11. Shaykhiev R, Otaki F, Bonsu P, Dang DT, Teater M, Strulovici-Barel Y, Salit J, Harvey BG, Crystal RG,. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell. Mol. Life Sci. 2011; 68: 877-892.
12. Comstock AT, Ganesan S, Chattoraj A, Faris AN, Margolis BL, Hershenson MB, Sajjan US,. Rhinovirus-induced barrier dysfunction in polarized airway epithelial cells is mediated by NADPH oxidase 1. J. Virol. 2011; 85: 6795-6808.
13. Bauer CM, Dewitte-Orr SJ, Hornby KR, Zavitz CC, Lichty BD, Stampfli MR, Mossman KL,. Cigarette smoke suppresses type I interferon-mediated antiviral immunity in lung fibroblast and epithelial cells. J. Interferon Cytokine Res. 2008; 28: 167-179.
14. Brusselle GG, Joos GF, Bracke KR,. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015-1026.
15. Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, et-al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010; 181: 917-927.
16. Lommatzsch M, Cicko S, Müller T, Lucattelli M, Bratke K, Stoll P, Grimm M, Dürk T, Zissel G, Ferrari D, et-al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010; 181: 928-934.
17. Mayer AK, Muehmer M, Mages J, Gueinzius K, Hess C, Heeg K, Bals R, Lang R, Dalpke AH,. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J. Immunol. 2007; 178: 3134-3142.
18. Cosio MG, Saetta M, Agusti A,. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 2009; 360: 2445-2454.
19. Barnes PJ, Shapiro SD, Pauwels RA,. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur. Respir. J. 2003; 22: 672-688.
20. Zhao CZ, Fang XC, Wang D, Tang FD, Wang XD,. Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease. Respir. Med. 2010; 104: 1391-1395.
21. Pichavant M, Taront S, Jeannin P, Breuilh L, Charbonnier AS, Spriet C, Fourneau C, Corvaia N, Héliot L, Brichet A, et-al. Impact of bronchial epithelium on dendritic cell migration and function: modulation by the bacterial motif KpOmpA. J. Immunol. 2006; 177: 5912-5919.
22. Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG,. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 175: 998-1005.
23. Salvi S, Holgate ST,. Could the airway epithelium play an important role in mucosal IgA production? Clin. Exp. Allergy 1999; 29: 1597-1605.
24. Pilette C, Ouadrhiri Y, Godding V, Vaerman JP, Sibille Y,. Lung mucosal immunity: immunoglobulin-A revisited. Eur. Respir. J. 2001; 18: 571-588.
25. Hogg JC,. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721.
26. Sutherland ER, Martin RJ,. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J. Allergy Clin. Immunol. 2003; 112: 819-827.
27. Zhang W, Case S, Bowler RP, Martin RJ, Jiang D, Chu HW,. Cigarette smoke modulates PGE(2) and host defence against Moraxella catarrhalis infection in human airway epithelial cells. Respirology 2011; 16: 508-516.
28. Chung KF,. Inflammatory mediators in chronic obstructive pulmonary disease. Curr. Drug Targets Inflamm. Allergy 2005; 4: 619-625.
29. Kafoury RM, Pryor WA, Squadrito GL, Salgo MG, Zou X, Friedman M,. Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. Am. J. Respir. Crit. Care Med. 1999; 160: 1934-1942.
30. Gray T, Nettesheim P, Loftin C, Koo JS, Bonner J, Peddada S, Langenbach R,. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol. Pharmacol. 2004; 66: 337-346.
31. Rao NL, Riley JP, Banie H, Xue X, Sun B, Crawford S, Lundeen KA, Yu F, Karlsson L, Fourie AM, et-al. Leukotriene A(4) hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2010; 181: 899-907.
32. Martin LD, Krunkosky TM, Voynow JA, Adler KB,. The role of reactive oxygen and nitrogen species in airway epithelial gene expression. Environ. Health Perspect. 1998; 106 (Suppl.): 1197-1203.
33. Ovrevik J, Lag M, Holme JA, Schwarze PE, Refsnes M,. Cytokine and chemokine expression patterns in lung epithelial cells exposed to components characteristic of particulate air pollution. Toxicology 2009; 259: 46-53.
34. Wu YL, Lin AH, Chen CH, Huang WC, Wang HY, Liu MH, Lee TS, Ru Kou Y,. Glucosamine attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling. Free Radic. Biol. Med. 2014; 69: 208-218.
35. Adenuga D, Rahman I,. Protein kinase ck2-mediated phosphorylation of hdac2 regulates co-repressor formation, deacetylase activity and acetylation of hdac2 by cigarette smoke and aldehydes. Arch. Biochem. Biophys. 2010; 498: 62-73.
36. Didon L, Barton JL, Roos AB, Gaschler GJ, Bauer CM, Berg T, Stämpfli MR, Nord M,. Lung epithelial CCAAT/enhancer-binding protein-beta is necessary for the integrity of inflammatory responses to cigarette smoke. Am. J. Respir. Crit. Care Med. 2011; 184: 233-242.
37. Lee SY, Kang EJ, Hur GY, Jung KH, Jung HC, Lee SY, Kim JH, Shin C, In KH, Kang KH, et-al. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006; 291: L84-90.
38. Pierrou S, Broberg P, O'Donnell RA, Pawłowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G, Möller S, et-al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 175: 577-586.
39. Vucic EA, Chari R, Thu KL, Wilson IM, Cotton AM, Kennett JY, Zhang M, Lonergan KM, Steiling K, Brown CJ, et-al. DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways. Am. J. Respir. Cell Mol. Biol. 2014; 50: 912-922.
40. Dong P, Fu X, Wang X, Wang WM, Cao WM, Zhang WY,. Protective effects of sesaminol on BEAS-2B cells impaired by cigarette smoke extract. Cell Biochem. Biophys. 2015; 71: 1207-1213.
41. Lakshmi SP, Reddy AT, Zhang Y, Sciurba FC, Mallampalli RK, Duncan SR, Reddy RC,. Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD). J. Biol. Chem. 2014; 289: 6383-6393.
42. Casalino-Matsuda SM, Monzon ME, Day AJ, Forteza RM,. Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium. Am. J. Respir. Cell Mol. Biol. 2009; 40: 277-285.
43. Yang T, Luo F, Shen Y, An J, Li X, Liu X, Ying B, Liao Z, Dong J, Guo L, et-al. Quercetin attenuates airway inflammation and mucus production induced by cigarette smoke in rats. Int. Immunopharmacol. 2012; 13: 73-81.
44. Goldkorn T, Filosto S,. Lung injury and cancer: mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am. J. Respir. Cell Mol. Biol. 2010; 43: 259-268.
45. Jabbour AJ, Altman LC, Wight TN, Luchtel DL,. Ozone alters distribution of β1 integrins in cultured primate bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 1998; 19: 357-365.
46. Slebos DJ, Ryter SW, van der Toorn M, Liu F, Guo F, Baty CJ, Karlsson JM, Watkins SC, Kim HP, Wang X, et-al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am. J. Respir. Cell Mol. Biol. 2007; 36: 409-417.
47. Comhair SA, Bhathena PR, Farver C, Thunnissen FB, Erzurum SC,. Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J. 2001; 15: 70-78.
48. Sthijns MM, Randall MJ, Bast A, Haenen GR,. Adaptation to acrolein through upregulating the protection by glutathione in human bronchial epithelial cells: the materialization of the hormesis concept. Biochem. Biophys. Res. Commun. 2014; 446: 1029-1034.
49. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S,. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2000; 23: 530-536.
50. van der Toorn M, Smit-de Vries MP, Slebos DJ, de Bruin HG, Abello N, van Oosterhout AJ, Bischoff R, Kauffman HF,. Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 293: L1156-1162.
51. Thornton DJ, Rousseau K, McGuckin MA,. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 2008; 70: 459-486.
52. Innes A, Woodruff P, Ferrando R, Donnelly S, Dolganov GM, Lazarus SC, Fahy JV,. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 2006; 130: 1102-1108.
53. Lai H, Rogers DF,. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. J. Aerosol. Med. Pulm. Drug. Deliv. 2010; 23: 219-231.
54. Fujisawa T, Chang MM, Velichko S, Thai P, Hung LY, Huang F, Phuong N, Chen Y, Wu R,. NF-κB mediates IL-1β- and IL-17A-induced MUC5B expression in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2011; 45: 246-252.
55. Gray T, Nettesheim P, Loftin C, Koo JS, Bonner J, Peddada S, Langenbach R,. Interleukin-1b-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol. Pharmacol. 2004; 66: 337-346.
56. Gray T, Coakley R, Hirsh A, Thornton D, Kirkham S, Koo JS, Burch L, Boucher R, Nettesheim P,. Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1b in human bronchial epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 286: L320-330.
57. Chiba T, Uchi H, Tsuji G, Gondo H, Moroi Y, Furue M,. Arylhydrocarbon receptor (AhR) activation in airway epithelial cells induces MUC5AC via reactive oxygen species (ROS) production. Pulm. Pharmacol. Ther. 2011; 24: 133-140.
58. Li N, Li Q, Zhou XD, Kolosov VP, Perelman JM,. The effect of quercetin on human neutrophil elastase-induced mucin5AC expression in human airway epithelial cells. Int. Immunopharmacol. 2012; 14: 195-201.
59. Deshmukh H, Shaver C, Case LM, Dietsch M, Wesselkamper SC, Hardie WD, Korfhagen TR, Corradi M, Nadel JA, Borchers MT, et-al. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am. J. Respir. Cell Mol. Biol. 2008; 38: 446-454.
60. Deshmukh HS, McLachlan A, Atkinson JJ, Hardie WD, Korfhagen TR, Dietsch M, Liu Y, Di PY, Wesselkamper SC, Borchers MT, et-al. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am. J. Respir. Crit. Care Med. 2009; 180: 834-845.
61. Boucher RC,. Relationship of airway epithelial ion transport to chronic bronchitis. Proc. Am. Thorac. Soc. 2004; 1: 66-70.
62. Allen-Gipson DS, Zimmerman MC, Zhang H, Castellanos G, O'Malley JK, Alvarez-Ramirez H, Kharbanda K, Sisson JH, Wyatt TA,. Smoke extract impairs adenosine wound healing: implications of smoke-generated reactive oxygen species. Am. J. Respir. Cell Mol. Biol. 2013; 48: 665-673.
63. Kalluri R, Weinberg RA,. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009; 119: 1420-1428.
64. Zhang M, Zhang Z, Pan HY, Wang DX, Deng ZT, Ye XL,. TGF-beta1 induces human bronchial epithelial cell-tomesenchymal transition in vitro. Lung 2009; 187: 187-194.
65. Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK, Wood-Baker R, Walters EH,. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 2010; 15: 930-938.
66. Puchelle E, Zahm JM, Tournier JM, Coraux C,. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006; 3: 726-733.
67. Lagente V, Manoury B, Nenan S, Le Quement C, Martin-Chouly C, Boichot E,. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz. J. Med. Biol. Res. 2005; 38: 1521-1530.
68. Leff AR,. Tissue remodeling and repair mechanisms in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006; 3: 734-736.
69. Schamberger AC, Mise N, Meiners S, Eickelberg O,. Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery. Expert. Opin. Drug. Discov. 2014; 9: 609-628.